About Contact Us Careers

Cancer Services Market - Top Companies and Manufacturers

Request Free Sample Copy

Report ID: 227
Published Date: Sep 11, 2024
Report Format: PDF, PPT

Buy Now

Companies Dominating the Cancer Services Landscape

Siemens Healthcare GmbH
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
Fonar Corporation
Koninklijke Philips N.V.
Shimadzu Corporation
Abbott Laboratories
Samsung Medison Co., Ltd.
Eli Lilly and Company
Hologic, Inc.
Novartis International AG
GE Group

Browse Key Market Insights with Data Illustration:

Cancer Services Market Size & Share - Growth Trends 2036

In the News

May 24, 2022: One of the major subsidiaries of Philips, Philips Respironics, provides voluntary recall notification for particular respiratory and sleep care products.
May 20, 2020: Novartis Cosentyx, a fully human biologic to inhibit interleukin-17A, receives a positive opinion of CHMP for the long-lasting utilization in arthritic conditions of children.

Author Credits: Radhika Pawar

Report ID: 227
Published Date: Sep 11, 2024
Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Increasing cases of cancer, a rising geriatric population, and growing consumption of alcohol, cigarettes, and tobacco are the major factors driving the growth of the cancer services market.

The market is anticipated to attain a CAGR of ~20% over the forecast period, i.e., 2022 - 2031.

The major players in the market are Siemens Healthcare GmbH, Fonar Corporation, Koninklijke Philips N.V., Shimadzu Corporation, Abbott Laboratories, Samsung Medison Co., Ltd., Eli Lilly and Company, Hologic, Inc., Novartis International AG, and GE Group.

Inquiry Before Buying Request Free Sample